Corporate Investors Boost M&A Step-Ups, But Not IPOs
This article was originally published in Start Up
Executive Summary
Corporate venture capital groups have made an impact on life science investing in recent years, but when it comes to going public, the biotechs they back aren’t seeing an extra boost.